HADLIMA
- Product NDC
- 50090-6705
- 11-digit product format
- 500906705
- Labeler code
- 50090
- Product ID
- 50090-6705_f29c7432-aeb1-4eea-b6b1-05572b973220
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- adalimumab-bwwd
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- A-S Medication Solutions
- Application
- BLA761059
- Marketing category
- BLA
- Marketing start
- 2023-07-01
- Substance
- ADALIMUMAB
- Active strength
- 40 mg/.8mL
- Pharmacologic classes
- Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- HADLIMA
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ADALIMUMAB | 40 mg/.8mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | FYS6T7F842 |
| Rxcui | 2640302, 2640305 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-6705-0 | HADLIMA | 1 in 1 CARTON | SOLUTION | 1 | | 3 |
| 50090-6705-0 | HADLIMA | .8 mL in 1 SYRINGE | SOLUTION | .8 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-6705 | HADLIMA (ADALIMUMAB-BWWD) SOLUTION [A-S MEDICATION SOLUTIONS] | 3 | Current NDC, 2 package rows | 20231102_7345f276-102e-4175-b7ef-ff1706b05472.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-6705-0 | 50090670500 | 1 SYRINGE in 1 CARTON (50090-6705-0) / .8 mL in 1 SYRINGE | 1 syringe | 2023-09-27 | No | No | Current |